Intellectual Property (IP)Displaying results 1 - 10 of 17
UNCTAD outlines actions to boost production of essential antibiotics in East Africa
24 Nov 2023
Three reports show how Ethiopia, Kenya and Uganda can broaden their investment incentives to capture the special needs of antibiotics production.
Ten actions to boost low and middle-income countries’ productive capacity for medicines
27 May 2020
Written by James Zhan, Director, Division on Investment and Enterprise, and Christoph Spennemann, Chief, Intellectual Property Unit, UNCTAD
COVID-19 heightens need for pharmaceutical production in poor countries
27 May 2020
UNCTAD and the WHO have teamed up to respond to the urgent call to boost local production of essential medicines in developing countries.
Intellectual Property and Development in the Digital Economy
10 Apr 2019
In the context of the e-commerce week, UNCTAD on 4 April 2019 organized a panel discussion on Intellectual Property and Development in the Digital Economy.
Fostering investment in the development of new antibacterial treatments
20 Nov 2018
An event on fostering investment in the development of new antibacterial treatments was held on 23 October 2018 at the Palais des Nations, Geneva during the World Investment Forum (WIF).
South Africa adopts new IP policy improving access to medicine
31 May 2018
UNCTAD applauds the decision of South Africa's Cabinet to approve the first phase of a new intellectual property policy that paves the way to better access to medicine in the country.
Fighting the war on antibiotic resistance with new investment schemes -- Q&A with Christoph Spennemann
20 Oct 2017
With medical experts warning of a "post-antibiotic apocalypse", UNCTAD legal officer Christoph Spennemann explains why joint public-private investment is the missing weapon in the war against the spread of antibiotic resistance.
East African pharma companies missing out on fast growing $5 billion opportunity
4 Nov 2016
The $5 billion East African pharmaceutical market is expected to grow by more than 12% per year for the next five years, as lifestyle changes in the region lead to higher rates of non-communicable diseases such as diabetes.
Investments needed to scale up access to essential medicines
17 Oct 2014
Improving access to medicines can be enhanced by local production of pharmaceuticals in developing countries. But to do so, both the public and the private sector need to work together, said James Zhan, Director of UNCTAD's Division on Investment and Enterprise at the World Investment Forum's Policy Debate on Public Health.